|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001721,
umls-concept:C0026809,
umls-concept:C0027803,
umls-concept:C0029347,
umls-concept:C0042760,
umls-concept:C0042765,
umls-concept:C0042774,
umls-concept:C0205224,
umls-concept:C0243126,
umls-concept:C0332437,
umls-concept:C1511625
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1996-2-22
|
|
pubmed:abstractText |
In this study, we investigated the role of the conserved neuraminidase (NA) cytoplasmic tail residues in influenza virus replication. Mutants of influenza A virus (A/WSN/33 [H1N1]) with deletions of the NA cytoplasmic tail region were generated by reverse genetics. The resulting viruses, designated NOTAIL, contain only the initiating methionine of the conserved six amino-terminal residues. The mutant viruses grew much less readily and produced smaller plaques than did the wild-type virus. Despite similar levels of NA cell surface expression by the NOTAIL mutants and wild-type virus, incorporation of mutant NA molecules into virions was decreased by 86%. This reduction resulted in less NA activity per virion, leading to the formation of large aggregates of progeny mutant virions on the surface of infected cells. A NOTAIL virus containing an additional mutation (Ser-12 to Pro) in the transmembrane domain incorporated three times more NA molecules into virions than did the NOTAIL parent but approximately half of the amount incorporated by the wild-type virus. However, aggregation of the progeny virions still occurred at the cell surface. All NOTAIL viruses were attenuated in mice. We conclude that the cytoplasmic tail of NA is not absolutely essential for virus replication but exerts important effects on the incorporation of NA into virions and thus on the aggregation and virulence of progeny virus. In addition, the relative abundance of long filamentous particles formed by the NOTAIL mutants, compared with the largely spherical wild-type particles, indicates a role for the NA cytoplasmic tail in virion morphogenesis.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-1378505,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-1647069,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-2016777,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-2069508,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-2339122,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-2482974,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-2547986,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-2585601,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-3323813,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-4472498,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-476051,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-5432063,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-6094954,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-6351727,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-6994339,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-7361453,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-7483820,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-7815489,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-7957116,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-8083965,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-8207822,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-8313876,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-8392617,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-8411379,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8551626-8480427
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0022-538X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
70
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
873-9
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:8551626-Amino Acid Sequence,
pubmed-meshheading:8551626-Animals,
pubmed-meshheading:8551626-Binding Sites,
pubmed-meshheading:8551626-Cell Line,
pubmed-meshheading:8551626-Female,
pubmed-meshheading:8551626-Humans,
pubmed-meshheading:8551626-Influenza A virus,
pubmed-meshheading:8551626-Mice,
pubmed-meshheading:8551626-Mice, Inbred BALB C,
pubmed-meshheading:8551626-Molecular Sequence Data,
pubmed-meshheading:8551626-Neuraminidase,
pubmed-meshheading:8551626-Proline,
pubmed-meshheading:8551626-Sequence Deletion,
pubmed-meshheading:8551626-Structure-Activity Relationship,
pubmed-meshheading:8551626-Virion,
pubmed-meshheading:8551626-Virulence,
pubmed-meshheading:8551626-Virus Replication
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication.
|
|
pubmed:affiliation |
Department of Virology and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
